The argument that Right to Try legislation is going to make more people have access to experimental medicines does not exist in my mind as a drug developer nor in anybody I know, and I can't say it more bluntly than that.
Burgess doubts the effectiveness of Right to Try legislation in improving access to experimental drugs.
Share
More from Michael Burgess
I never expected that CMMI was actually going to deliver the cost savings that was promised.
I urge all my fellow colleagues to join me in supporting H.R. 766 and ensuring that we continue to prioritize preventive healthcare initiatives for the betterment of all Americans, and I reserve the balance of my time.
I thank the gentleman for yielding additional time. However, one-sided pressure by the White House is not the way to ensure that end. Mr. Speaker, I urge passage of this rule from our committee, and I urge passage of the underlying…
This has all been so moving and so lovely, but if anyone tuned in late tonight in C-SPAN, they probably thought I passed because it really did sound like a eulogy. I am still here, and I will continue to text and call and inform everyone…
Other voices in this conversation
